Urticaria (Hives) Support Protocol

Dermatological/AllergicLimited Evidence
5
supplements
2
Primary
3
Supporting
0
Grade A
29
Studies

Primary Stack

Core supplements with strongest evidence
2000-4000 IU daily

Deficiency linked to chronic urticaria; supports immune modulation

10 studies500 participants
10-20 billion CFU daily

May help modulate immune response in chronic urticaria

6 studies250 participants

Supporting Stack

Additional supplements for enhanced results
1000-2000mg daily

Natural antihistamine properties; reduces histamine levels

5 studies200 participants
500-1000mg daily

Mast cell stabilizer; may reduce histamine release

4 studies150 participants
2-3g EPA+DHA daily

Anti-inflammatory; may help with chronic inflammatory conditions

4 studies150 participants

How This Protocol Works

Simple Explanation

Urticaria (hives) causes itchy, raised, red welts on the skin. It's caused by the release of histamine and other chemicals from cells in the skin.

TYPES:

•Acute urticaria (<6 weeks) - usually allergic or viral
•Chronic urticaria (>6 weeks) - often no identifiable cause
•Physical urticarias (triggered by cold, heat, pressure, sunlight)
•Chronic spontaneous urticaria (most common chronic type)

COMMON TRIGGERS:

•Foods (nuts, eggs, shellfish)
•Medications (NSAIDs, antibiotics)
•Infections
•Insect stings
•Physical triggers (pressure, cold, heat)
•Stress
•Often no identifiable trigger

SYMPTOMS:

•Itchy welts (wheals)
•Red or skin-colored
•Vary in size
•Come and go
•May have angioedema (deeper swelling)

SEEK EMERGENCY CARE IF:

•Difficulty breathing
•Throat tightness
•Swelling of lips/tongue
•Dizziness or fainting

TREATMENT:

•Antihistamines (first-line)
•Avoid triggers if known
•Cool compresses
•For severe: omalizumab, cyclosporine

* Vitamin D deficiency is common in chronic urticaria.

* Antihistamines remain first-line treatment.

* Identify and avoid triggers when possible.

Expected timeline: Acute urticaria usually resolves within days to weeks. Chronic urticaria may last months to years but often eventually resolves.

Clinical Perspective

Urticaria: Mast cell activation with histamine release. Acute (<6 weeks): often allergic, viral, idiopathic. Chronic (>6 weeks): chronic spontaneous urticaria (CSU) most common; autoimmune component in 30-50%. Physical urticarias: dermographism, cold, cholinergic, pressure.

Treatment: Non-sedating H1 antihistamines first-line (can up-dose 4x). Add H2 blocker, leukotriene antagonist. Refractory: omalizumab (anti-IgE) highly effective. Cyclosporine for severe. Vitamin D: multiple studies show deficiency in CSU; supplementation may improve. Supplements adjunctive; antihistamines remain primary.

* Vitamin D (B-grade): Deficiency common. Systematic review: (PMID: 28750270). 2000-4000 IU daily.

* Probiotics (C-grade): Immune modulation. Review: (PMID: 24045160). 10-20B CFU daily.

* Vitamin C (C-grade): Antihistamine. Review: (PMID: 23440782). 1000-2000mg daily.

* Quercetin (C-grade): Mast cell stabilizer. Review: (PMID: 27187333). 500-1000mg daily.

* Omega-3 (C-grade): Anti-inflammatory. Review: (PMID: 27840029). 2-3g EPA+DHA daily.

Protocol notes: Acute: identify trigger if possible; anaphylaxis protocol if severe. Chronic: workup limited unless features suggest underlying cause. Antihistamines: up-dose before adding other agents. Omalizumab: very effective for refractory CSU. Thyroid: check; autoimmune thyroid associated. Angioedema: if with urticaria, usually mast cell-mediated; if without, consider ACEi-related or hereditary. Autoimmune screen if features suggest. Quality of life: significantly impacted; assess and support.